Overview of disease pathology and discussion advancements in immunotherapy for the treatment of uveal melanoma

Abstract excerpt

<title>Abstract</title> <p> Uveal melanoma is a rare and refractory subtype of melanoma. ¹ Approximately 50% of patients diagnosed with uveal melanoma die within one year, and an effective standard of care treatment has yet to be established. ² It affects men and women equally but primarily affects middle-aged individuals. ³ Metastatic uveal melanoma predominantly spreads t...

Topics

Open a Topic to create a Post that cites this publication.

• Antineoplastic Agents
• Immunotherapy
• Melanoma
• Molecular Targeted Therapy
• Mutation
• Neoplasm Metastasis
• Uveal Melanoma
• Uveal Neoplasms

Identifiers and source

Literature Corpus work

415f933a-56de-5af2-a20b-109d2c731947

DOI

10.21203/rs.3.rs-7794706/v1